MD-PhD (TU-LMU Munich), MPH (Harvard), MBA (Kellogg), FACPE (Australia), GAICD
Dr Gisela Mautner has more than 20 years of extensive leadership experience in global pharmaceutical organisations, including operational, medical and scientific advisory roles across multiple therapeutic areas. During her career she held senior positions at global pharmaceutical companies like MSD (Merck), Bayer and Amgen in Germany as well as Australia.
She holds a Doctor of Medicine degree and a PhD from Germany, a Master of Public Health (MPH) from Harvard University, and a Master of Business Administration (MBA) from Northwestern University of Chicago.
She is a Graduate of the Australian Institute of Company Directors (GAICD), a Health Industry Hub STEM Champion Award winner, as well as the first-ever recipient of the Brooker Prize Impact Award.
Gisela was appointed Chief Executive Officer and Managing Director of Noxopharm in 2022.
